The open index of psychedelic research

A model to simulate cardio-respiratory responses to fentanyl analgesia after traumatic injury.

Kurian V, Jin X, Wallqvist A +2

The therapeutic potential of psychedelic drugs: past, present, and future

Nutt D

Boundaries or boundlessness? Toward knowledge co-creation in psychedelic-assisted therapy

Psychedelic Renaissance: A New Paradigm in Mental Health

Matas Ochoa A, Quiroga A, Sacristán I

Wellbeing and Sensory Experiences of Naturalistic Psychedelic Use among Autistic Adults Engaged in Therapeutic Psychedelic Use

Implementing psychedelic-assisted therapy in Ireland: perspectives from a national stakeholder survey.

Harrington C, Mallon O, Gribben AD +7

A Molecule-Resolved Bibliometric Analysis of PubMed-Indexed Psychedelic Research (2015–2025): Volume, Temporal Trends, and Publication Types

Pastuszak M, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M +4

No more harm: A guiding principle of psychedelic drug policy

[Research progress on the role of claustrum in substance use disorders].

Wu M, Zhou W, Zhao M

Novel pharmacotherapies for opioid use disorder and opioid withdrawal.

Shen MR, Owusu-Boaitey K, Murphy ZD +4

Hallucinogen Persisting Perception Disorder in a Young Adult Case Report.

Notani S, Srinivasa V, Chaudhry S +1

A rapid systematic review of palliative uses of ketamine for depression and pain in people living with advanced cancer.

Tometich DB, Hersh CL, Murphy MA +4

Successful Management Of Refractory Precipitated Opioid Withdrawal Syndrome Following Buprenorphine Intake Using Ketamine: A Case Report

Torik IA, Moeini M, Moghaddam S +1

Ketamine in ambulatory anesthesia: dose-dependent effects on breathing and cortical function.

Azimaraghi O, Wongtangman K, Suleiman A +1

Ketamine Addiction With Multisystem Toxicity: A Case Report From Canon Lan Detox Unit, Neath Port Talbot Hospital, South Wales

Omisakin O, Gangineni M, Davies A

Safety, pharmacokinetics, and pharmacodynamics of intravenously administered deuterated <i>N,N</i>-dimethyltryptamine (CYB004) in healthy volunteers.

van der Heijden KV, Jacobs GE, James EH +6

Short-term ketamine interventions for depressive disorders: practical best-practice recommendations for psychiatrists using oral, subcutaneous, and nasal formulations.

Słupska A, Cubała WJ, Swieczkowski D +3

Ketamine Dependence: Clinical Characteristics of an Inpatient Detoxification Population With Complex Physical Health Needs

Shackleton S, Oni O, Kaar S

Trial of Subcutaneous Ketamine for Psychotic Depression in an Older Adult With Comorbid Physical Illness: A Case Report

Ganeshan R, Zacharia T

Effectiveness of IV Ketamine Therapy in the Management of Treatment Resistant Depression

Dogar I, Sajid P, Fatima D +2

Interpreting Perineural Esketamine for Analgesia After Total Knee Arthroplasty: Methodological and Reporting Considerations [Response to Letter].

Wang Y, Hong L, Wang P +1

Clinical utility and tolerability of ketamine as adjunctive rescue therapy for refractory neonatal status epilepticus: a case report of a late preterm infant with multifocal hemorrhagic brain injury.

Gulisano C, Pepe A, Amadori E +6

Structure-based molecular modeling of a novel S-Remiketamine scaffold and derived arylcyclohexanone analogues: NMDA receptor dynamics, MM-GBSA ranking, and CES1-Oriented structural compatibility.

Alkhatip AAAMM, Raza U, Farag E +9

Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.

Heles M, Pasvolsky L, Sathishkumar H +27